Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
US6822071B1 · kind B1 · utility
50Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 11, 1999 |
| Grant date | Nov 23, 2004 |
| Priority date | — |
| Expiry date | Nov 11, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chlamydia pneumoniae polypeptides are provided. The C. pneumoniae polypeptides can be used to prepare pharmaceutical compositions for the treatment or prevention of disease. In addition, the proteins can be used in methods for the diagnosis of C. pneumoniae infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.